Mixed lineage kinase 3 inhibits platelet-derived growth factor-stimulated DNA synthesis and matrix mRNA expression in mesangial cells

Cellular Physiology and Biochemistry

Volumn 12, Issue 5-6, 2002, Pages 325-334

  Parameswaran, Narayanan ^a   Hall, Carolyn ^a   Boeck, Barbara ^a   Sparks, Harvey ^a   Gallo, Kathleen ^a   Spielman, William ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Kidney; Mesangial cells; MLK 3; PDGF

Indexed keywords

COLLAGEN TYPE 1; DNA; ENDOTHELIN RECEPTOR AGONIST; FIBRONECTIN; ISOENZYME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGENIC AGENT; MIXED LINEAGE KINASE 3; PLATELET DERIVED GROWTH FACTOR; SARAFOTOXIN S6B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; THYMIDINE; UNCLASSIFIED DRUG; ANISOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11; SARAFOTOXINS S6; VIPER VENOM;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; GENETIC TRANSFECTION; GROWTH REGULATION; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE VECTOR; GENETICS; HUMAN; MESANGIUM; METABOLISM; MOLECULAR CLONING; MUTATION; NORTHERN BLOTTING; WESTERN BLOTTING;

ANIMALS; ANISOMYCIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; CLONING, MOLECULAR; COLLAGEN TYPE I; DNA; ENZYME ACTIVATION; FIBRONECTINS; GENETIC VECTORS; GLOMERULAR MESANGIUM; HUMANS; MALE; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PLATELET-DERIVED GROWTH FACTOR; RATS; RNA, MESSENGER; VIPER VENOMS;

EID: 0036432870     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067902     Document Type: Article

References (29)

1. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318:1657-1666.
2. Abboud HE: Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 1995;57:297-309.
3. Floege J, Johnson RJ: Multiple roles for platelet-derived growth factor in renal disease. Miner Electrolyte Metab 1995;21:271-82.
4. Benigni A, Remuzzi G: Endothelin in the progressive renal disease of glomerulopathies. Miner Electrolyte Metab 1995;21:283-291.
5. Naicker S, Bhoola KD: Endothelins: Vasoactive modulators of renal function in health and disease. Pharmacol Ther 2001;90:61-88.
6. Gallo KA, Mark MR, Scadden DT, Wang Z, Gu Q, Godowski PJ: Identification and characterization of SPRK, a novel srchomology 3 domain-containing proline-rich kinase with serine/threonine kinase activity. J Biol Chem 1994;269:15092-100.
7. Bock BC, Vacratsis PO, Qamirani E, Gallo KA: Cdc42-induced activation of the mixed-lineage kinase SPRK in vivo. Requirement of the Cdc42/Rac interactive binding motif and changes in phosphorylation. J Biol Chem 2000;275:14231-14241.
8. Dickens M, Rogers JS, Cavanagh J, et al.: A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 1997;277:693-696.
9. Hartkamp J, Troppmair J, Rapp UR: The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. Cancer Res 1999;59:2195-2202.
10. Rana A, Gallo K, Godowski P, et al.: The mixed lineage kinase SPRK phosphorylates and activates the stress- activated protein kinase activator, SEK-1. J Biol Chem 1996;271:19025-19028.
11. Tibbles LA, Ing YL, Kiefer F, et al.: MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. Embo J 1996;15:7026-7035.
12. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ: A mammalian scaffold complex that selectively mediates MAP kinase activation [see comments]. Science 1998;281:1671-1674.
13. Mota M, Reeder M, Chernoff J, Bazenet CE: Evidence for a role of mixed lineage kinases in neuronal apoptosis. J Neurosci 2001;21:4949-4957.
14. Xu Z, Maroney AC, Dobrzanski P, Kukekov NV, Greene LA: The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol Cell Biol 2001;21:4713-4724.
15. Albrightson CR, Nambi P, Zabko-Potapovich B, Dytko G, Groom T: Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture. J Pharmacol Exp Ther 1992;263:404-412.
16. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
17. Nambi P, Pullen M, Wu HL, Prabhakar U, Hersh L, Gellai M: Down regulation of kidney neutral endopeptidase mRNA, protein and activity during acute renal failure: Possible mechanism for ischemia- induced acute renal failure in rats? Mol Cell Biochem 1999;197:53-59.
18. Widmann C, Gibson S, Jarpe MB, Johnson GL: Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 1999;79:143-180.
19. Hoffmeyer A, Grosse-Wilde A, Flory E, et al.: Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor alpha gene expression in T lymphocytes. J Biol Chem 1999;274:4319-4327.
20. Hehner SP, Li-Weber M, Giaisi M, Droge W, Krammer PH, Schmitz ML: Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells. J Immunol 2000;164:3829-3836.
21. Hehner SP, Hofmann TG, Ushmorov A, et al.: Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. Mol Cell Biol 2000;20:2556-2568.
22. Betsholtz C, Raines EW: Platelet-derived growth factor: A key regulator of connective tissue cells in embryogenesis and pathogenesis. Kidney Int 1997;51:1361-1369.
23. Johnson RJ, Raines EW, Floege J, et al.: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992;175:1413-1416.
24. Choudhury GG: Akt serine threonine kinase regulates platelet-derived growth factor- induced DNA synthesis in glomerular mesangial cells: Regulation of c- fos AND p27(kip1) gene expression. J Biol Chem 2001;276:35636-35643.
25. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN: Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 2000;11:2222-2230.
26. Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T: Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 2001;276:7957-7962.
27. Isono M, Haneda M, Maeda S, Omatsu-Kanbe M, Kikkawa R: Atrial natriuretic peptide inhibits endothelin-1-induced activation of JNK in glomerular mesangial cells. Kidney Int 1998;53:1133-1142.
28. Inui D, Yoshizumi M, Suzaki Y, et al.: Effect of endothelin-1(1-31) on p38 mitogen-activated protein kinase in cultured human mesangial cells. Life Sci 2000;68:635-645.
29. Tsiani E, Lekas P, Fantus IG, Dlugosz J, Whiteside C: High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor. Am J Physiol Endocrinol Metab 2002;282:E161-E169.